Becton Dickinson (NYSE:BDX) beat the consensus forecast on Wall Street today with its preliminary fiscal 2019 first quarter results and confirmed its outlook for the rest of fiscal 2019. The Franklin Lakes, N.J.-based healthcare giant said it expects to post adjusted earnings per share of $2.70 on sales of $4.16 billion for the three months ended Dec. […]
Becton Dickinson’s Q4 meets earnings expectations, beats on revenue
Becton Dickinson & Co. (NYSE:BDX) today met the consensus earnings forecasts and beat revenue expectations for both its fiscal fourth-quarter and full-year results, despite a Q4 swing to red. The Franklin Lakes, N.J.-based healthcare giant posted losses of -$173 million, or -64¢ per share, on sales of $4.40 billion for the three months ended Sept. 30, […]
LeMaitre Vascular puts up $2m for BD’s Cardial
LeMaitre Vascular (NSDQ:LMAT) said today it inked a deal to acquire Becton Dickinson‘s (NYSE:BDX) Cardial subsidiary for approximately $2.3 million (EU €2 million). The Saint-Étienne, France-based subsidiary produces knitted and woven vascular grafts, valvulotomes and surgical glue, and reported approximately $3.3 million (EU €2.9 million) in sales over the past 12 months, Burlington, Mass.-based LeMaitre said. […]
FDA releases BD lock flush syringe facility warning letter
The FDA this week released a warning letter it sent to Becton Dickinson (NYSE: BDX) last month over issues it found at the company’s Franklin, Wisc.-based facilities, which produces pre-filled Heparin and 0.9% sodium chloride lock flush syringes. The warning letter came from an inspection of the facilities which took place between May 16, 2018 and August […]
BD uses Carbon’s 3D tech to mold intricate part
Becton, Dickinson and Company (BD) has begun producing parts based on Carbon’s digital light synthesis technology, including BD’s first production part using additive manufacturing — a hemocytometer adapter for the company’s Rhapsody single-cell genomic analysis system. This component would have been impractical and expensive to injection mold, according to Redwood City, Calif.–based Carbon, which said it offered […]
BD’s Bard reported to win third IVC bellwether
A federal jury in Arizona reportedly found for Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard today in a bellwether product liability case brought over its inferior vena cava filters. Although it’s the fourth bellwether case in the multi-district litigation over the IVC devices, which are designed to prevent blood clots from passing through the body’s […]
Judge pares claims in Bard IVC bellwether
A federal judge in Arizona yesterday pared some claims in the third bellwether case involving inferior vena cava filters made by Becton Dickinson (NYSE:BDX) subsidiary C.R. Bard, as the trial entered its 11th day. It’s the fourth bellwether in the multi-district litigation over the IVC devices, which are designed to prevent blood clots from passing through […]
BD promotes Polen to COO | Personnel Moves – October 3, 2018
Becton Dickinson (NYSE:BDX) said today it named current president Tom Polen as its new chief operating officer, filling a role that has been empty since 2016. Polen was appointed president in April 2017, and will continue to report to chairman and CEO Vincent Forlenza, the Franklin Lakes, N.J.-based company said. In his new position, Polen will […]
The 20 largest medical device companies in the world
The medical device industry saw even more consolidation over the past year, as evidenced by Medical Design & Outsourcing‘s newest Big 100 list. It used to be that a company had to have at least $100 million in annual revenue to make it on the list. This time around, No. 100 on the list is […]
BD deals bioprocessing biz to Thermo Fisher
Thermo Fisher (NYSE:TMO) said yesterday it inked a deal to pick up Becton Dickinson‘s (NYSE:BDX) Advanced Bioprocessing business for an undisclosed amount. The divested assets include a technical services program with a variety of peptones intended to enhance cell culture media formulations to improve yield and reduce variability in biopharmaceutical applications, Thermo Fisher said. The Advanced Bioprocessing […]
BD inks UAE insulin pen distro deal with Julphar
Pharmaceutical manufacturer Julphar said yesterday it inked a deal with BD (NYSE: BDX) to supply disposable insulin pens to the United Arab Emirates. Through the deal, individuals will be able to purchase BD’s Vystra disposable pens featuring Julphar’s human insulin formulations, including its Jusline R, Jusline N and Jusline 30/70. The same system is slated to be […]
- 1
- 2
- 3
- …
- 29
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube